77 related articles for article (PubMed ID: 26092169)
1. Binding of topotecan to chromatin: Insights into cooperative binding and comparison with DNA.
Babaei M; Rabbani-Chadegani A; Ghadam P
Int J Biol Macromol; 2015 Sep; 80():57-63. PubMed ID: 26092169
[TBL] [Abstract][Full Text] [Related]
2. Exploring binding affinity of oxaliplatin and carboplatin, to nucleoprotein structure of chromatin: spectroscopic study and histone proteins as a target.
Soori H; Rabbani-Chadegani A; Davoodi J
Eur J Med Chem; 2015 Jan; 89():844-50. PubMed ID: 25462284
[TBL] [Abstract][Full Text] [Related]
3. Activity of Topotecan toward the DNA/Topoisomerase I Complex: A Theoretical Rationalization.
Bali SK; Marion A; Ugur I; Dikmenli AK; Catak S; Aviyente V
Biochemistry; 2018 Mar; 57(9):1542-1551. PubMed ID: 29412654
[TBL] [Abstract][Full Text] [Related]
4. [Interaction of topotecan, DNA topoisomerase I inhibitor, with double-stranded polydeoxyribonucleotides. 4. Topotecan binds preferably to the GC base pairs of DNA].
Strel'tsov SA; Mikheĭkin AL; Grokhovskiĭ SL; Oleĭnikov VA; Kudelina IA; Zhuze AL
Mol Biol (Mosk); 2002; 36(5):912-30. PubMed ID: 12391856
[TBL] [Abstract][Full Text] [Related]
5. Spectroscopic detection of etoposide binding to chromatin components: the role of histone proteins.
Chamani E; Rabbani-Chadegani A; Zahraei Z
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Dec; 133():292-9. PubMed ID: 24954753
[TBL] [Abstract][Full Text] [Related]
6. Interaction of clinically important human DNA topoisomerase I poison, topotecan, with double-stranded DNA.
Streltsov S; Oleinikov V; Ermishov M; Mochalov K; Sukhanova A; Nechipurenko Y; Grokhovsky S; Zhuze A; Pluot M; Nabiev I
Biopolymers; 2003; 72(6):442-54. PubMed ID: 14587067
[TBL] [Abstract][Full Text] [Related]
7. Structural spectroscopy and dynamics of inter- and intramolecular H-bonding interactions of topotecan, a potent anticancer drug, in organic solvents and in aqueous solution.
di Nunzio MR; Wang Y; Douhal A
J Phys Chem B; 2012 Jun; 116(25):7522-30. PubMed ID: 22662747
[TBL] [Abstract][Full Text] [Related]
8. [Interaction of topotecan, DNA topoisomerase I inhibitor, with double-stranded polydeoxyribonucleotides. III. Binding at the minor groove].
Strel'tsov SA; Mikheĭkin AL; Grokhovskiĭ SL; Oleĭnikov VA; Zhuze AL
Mol Biol (Mosk); 2002; 36(3):511-24. PubMed ID: 12068638
[TBL] [Abstract][Full Text] [Related]
9. [Studies by means of 1H NMR spectroscopy of complex formation of aromatic biologically active compounds with antibiotic topotecan].
Mosunov AA; Kostiukov VV; Evstigneev MP
Ukr Biokhim Zh (1999); 2012; 84(2):61-72. PubMed ID: 22642123
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the interaction between berberine and nucleosomes in solution: Spectroscopic and equilibrium dialysis approach.
Rabbani-Chadegani A; Mollaei H; Sargolzaei J
Spectrochim Acta A Mol Biomol Spectrosc; 2017 Feb; 173():418-424. PubMed ID: 27705846
[TBL] [Abstract][Full Text] [Related]
11. Spectroscopic analysis of the interaction of valproic acid with histone H1 in solution and in chromatin structure.
Sargolzaei J; Rabbani-Chadegani A; Mollaei H; Deezagi A
Int J Biol Macromol; 2017 Jun; 99():427-432. PubMed ID: 28263810
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of the interaction of plant alkaloid vincristine with DNA and chromatin: spectroscopic study.
Mohammadgholi A; Rabbani-Chadegani A; Fallah S
DNA Cell Biol; 2013 May; 32(5):228-35. PubMed ID: 23590199
[TBL] [Abstract][Full Text] [Related]
13. Studies on the binding affinity of anticancer drug mitoxantrone to chromatin, DNA and histone proteins.
Hajihassan Z; Rabbani-Chadegani A
J Biomed Sci; 2009 Mar; 16(1):31. PubMed ID: 19284573
[TBL] [Abstract][Full Text] [Related]
14. A Novel Polymer-Lipid Hybrid Nanoparticle for the Improvement of Topotecan Hydrochloride Physicochemical Properties.
Silva EJ; Souza LG; Silva LAD; Taveira SF; Guilger RC; Liao LM; Queiroz Junior LHK; Santana MJ; Marreto RN
Curr Drug Deliv; 2018; 15(7):979-986. PubMed ID: 29243576
[TBL] [Abstract][Full Text] [Related]
15. Investigation on the chromium oxide interaction with soluble chromatin and histone H1: a spectroscopic study.
Khorsandi K; Rabbani-Chadegani A
Int J Biol Macromol; 2014 Sep; 70():57-63. PubMed ID: 24960121
[TBL] [Abstract][Full Text] [Related]
16. Caffeine prevents apoptosis and cell cycle effects induced by camptothecin or topotecan in HL-60 cells.
Traganos F; Kapuscinski J; Gong J; Ardelt B; Darzynkiewicz RJ; Darzynkiewicz Z
Cancer Res; 1993 Oct; 53(19):4613-8. PubMed ID: 8402636
[TBL] [Abstract][Full Text] [Related]
17. The role of pH and ring-opening hydrolysis kinetics on liposomal release of topotecan.
Fugit KD; Anderson BD
J Control Release; 2014 Jan; 174():88-97. PubMed ID: 24231406
[TBL] [Abstract][Full Text] [Related]
18. Insights into accelerated liposomal release of topotecan in plasma monitored by a non-invasive fluorescence spectroscopic method.
Fugit KD; Jyoti A; Upreti M; Anderson BD
J Control Release; 2015 Jan; 197():10-9. PubMed ID: 25456833
[TBL] [Abstract][Full Text] [Related]
19. Ion-Pairing Contribution to the Liposomal Transport of Topotecan as Revealed by Mechanistic Modeling.
Fugit KD; Anderson BD
J Pharm Sci; 2017 Apr; 106(4):1149-1161. PubMed ID: 28007561
[TBL] [Abstract][Full Text] [Related]
20. Spectroscopic studies of dactinomycin and vinorelbine binding to deoxyribonucleic acid and chromatin.
Rabbani-Chadegani A; Keyvani-Ghamsari S; Zarkar N
Spectrochim Acta A Mol Biomol Spectrosc; 2011 Dec; 84(1):62-7. PubMed ID: 21981942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
